{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,14]],"date-time":"2025-12-14T09:07:07Z","timestamp":1765703227144,"version":"3.48.0"},"reference-count":33,"publisher":"BMJ","issue":"6","license":[{"start":{"date-parts":[[2025,6,30]],"date-time":"2025-06-30T00:00:00Z","timestamp":1751241600000},"content-version":"unspecified","delay-in-days":29,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"accepted":{"date-parts":[[2025,6,17]]},"published-print":{"date-parts":[[2025,6]]},"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Haemostasis, a process involving platelet activation, platelet aggregation and coagulation, poses intricate clinical challenges for clinicians. There remains significant national variability in thromboprophylaxis protocols, which are used in 77\u201382% of surgical cases in Australia. There is also increasing concern focused on the development of antiplatelet resistance. Given an apparent lack of standardised approaches to haemostasis, these decisions frequently require clinician discretion and can result in suboptimal outcomes. To optimise patient management, all available therapeutic agents should be considered. Current standards may need to be revised accordingly.<\/jats:p>\n                    <jats:p>Dextrans are polysaccharides with perioperative significance in haemostasis. Although the proposed mechanisms of dextran action are multifactorial, these agents may have a significant impact in cases of trauma, reconstructive surgery, transplantation and vascular surgery. However, a suspected deficit in the quality of the literature, and therefore clinical standardisation, raises concerns for optimal incorporation into practice.<\/jats:p>\n                    <jats:p>Accordingly, we plan to examine both peer-reviewed articles and \u2018grey\u2019 literature that considers the indications, efficacy and complications associated with the clinical use of dextrans to promote haemostasis. The primary objective of this scoping review will be to analyse and map the existing literature on the use of dextrans in both operative and non-operative settings and provide insight that will bridge the current knowledge gap and guide future research initiatives.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and analysis<\/jats:title>\n                    <jats:p>The study and literature search will be performed in accordance with recommendations adapted for scoping reviews in alignment with Preferred Reporting Items for Systematic Reviews and Meta-Analyses for Scoping Reviews standards. A thorough and systematic investigation will be undertaken across several electronic databases, including EMBASE, the Cochrane Library and MEDLINE; additional studies will be accessed and examined by reference tracking. All relevant research published before 11 March 2024 will be reviewed for appropriateness of inclusion. Two researchers will perform data screening and extraction of relevant information. Study observations will be presented in a descriptive manner using a mixed methods and narrative approach.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Ethics and dissemination<\/jats:title>\n                    <jats:p>Ethics approval was not required for this study. The results will be disseminated through publication in open-access peer-reviewed journals, established professional networks and conference presentations.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjopen-2024-092284","type":"journal-article","created":{"date-parts":[[2025,6,30]],"date-time":"2025-06-30T14:40:20Z","timestamp":1751294420000},"page":"e092284","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":1,"title":["Dextrans as anticoagulants and antiplatelet agents: protocol for a scoping review"],"prefix":"10.1136","volume":"15","author":[{"given":"Ariane","family":"Flinkier","sequence":"first","affiliation":[{"name":"Department of Anaesthesia, Austin Health, Heidelberg, Victoria, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suwandi","family":"Dewapura","sequence":"additional","affiliation":[{"name":"Department of Anaesthesia, Austin Health, Heidelberg, Victoria, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hai","family":"Tran","sequence":"additional","affiliation":[{"name":"Department of Anaesthesia, Austin Health, Heidelberg, Victoria, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zoe","family":"Yin","sequence":"additional","affiliation":[{"name":"Department of Anaesthesia, Austin Health, Heidelberg, Victoria, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nghiep","family":"Tran","sequence":"additional","affiliation":[{"name":"Department of Anaesthesia, Austin Health, Heidelberg, Victoria, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jordan","family":"Berman","sequence":"additional","affiliation":[{"name":"Department of Surgery, St Vincent\u2019s Hospital (Melbourne) Limited, Fitzroy, Victoria, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vidhura","family":"Ratnasekara","sequence":"additional","affiliation":[{"name":"Department of Anaesthesia, The Western Hospital, Victoria, Victoria, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nattaya","family":"Raykateeraroj","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology, Mahidol University Faculty of Medicine Siriraj Hospital, Bangkok, Bangkok, Thailand"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Fink","sequence":"additional","affiliation":[{"name":"Department of Surgery, The University of Melbourne, Melbourne, Victoria, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4068-2363","authenticated-orcid":false,"given":"Dong Kyu","family":"Lee","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology and Pain Medicine, Dongguk University Ilsan Hospital, Goyang, The Republic of Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7403-7680","authenticated-orcid":false,"given":"Laurence","family":"Weinberg","sequence":"additional","affiliation":[{"name":"Department of Anaesthesia, Austin Health, Heidelberg, Victoria, Australia"},{"name":"Department of Critical Care, The University of Melbourne, Melbourne, Victoria, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2025,6,30]]},"reference":[{"key":"2025121401034394000_15.6.e092284.1","doi-asserted-by":"publisher","DOI":"10.1213\/ANE.0b013e318240d6eb"},{"key":"2025121401034394000_15.6.e092284.2","doi-asserted-by":"publisher","DOI":"10.3310\/hta9400"},{"key":"2025121401034394000_15.6.e092284.3","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1097\/TP.0000000000002092","article-title":"Perioperative Coagulation Management in Liver Transplant Recipients","volume":"102","author":"Bezinover","year":"2018","journal-title":"Transplantation"},{"key":"2025121401034394000_15.6.e092284.4","unstructured":"ANZASM National Report 2019-2020 . Royal australiasian college of surgeons. 2020.30\u20133."},{"key":"2025121401034394000_15.6.e092284.5","doi-asserted-by":"crossref","unstructured":"Krishnan K , Nguyen TN , Appleton JP , et al . Antiplatelet Resistance: A Review of Concepts, Mechanisms, and Implications for Management in Acute Ischemic Stroke and Transient Ischemic Attack. SVIN 2023;3. doi:10.1161\/SVIN.122.000576","DOI":"10.1161\/SVIN.122.000576"},{"key":"2025121401034394000_15.6.e092284.6","doi-asserted-by":"crossref","unstructured":"Loc\u0101ne S , P\u016bc\u012bte E , Migl\u0101ne E , et al . Antiplatelet Resistance in Patients with Atherosclerosis. Proceedings of the Latvian Academy of Sciences Section B Natural, Exact, and Applied Sciences 2019;73:373\u20138. doi:10.2478\/prolas-2019-0058","DOI":"10.2478\/prolas-2019-0058"},{"key":"2025121401034394000_15.6.e092284.7","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1515\/jccm-2015-0021","article-title":"Anti-platelet Therapy Resistance - Concept, Mechanisms and Platelet Function Tests in Intensive Care Facilities","volume":"2","author":"M\u0103rginean","year":"2016","journal-title":"J Crit Care Med (Targu Mures)"},{"key":"2025121401034394000_15.6.e092284.8","doi-asserted-by":"publisher","DOI":"10.1001\/archsurg.1967.01330110080011"},{"key":"2025121401034394000_15.6.e092284.9","doi-asserted-by":"crossref","unstructured":"Sigurjonsson J , Hedman D , Bansch P , et al . Comparison of dextran and albumin on blood coagulation in patients undergoing major gynaecological surgery. Perioper Med 2018;7. doi:10.1186\/s13741-018-0100-0","DOI":"10.1186\/s13741-018-0100-0"},{"key":"2025121401034394000_15.6.e092284.10","unstructured":"Handbook of Thromboprophylaxis. 3rd edn. Adis, 2016."},{"key":"2025121401034394000_15.6.e092284.11","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1007\/s40140-021-00511-z","article-title":"Perioperative Guidelines on Antiplatelet and Anticoagulant Agents: 2022 Update","volume":"12","author":"Moster","year":"2022","journal-title":"Curr Anesthesiol Rep"},{"key":"2025121401034394000_15.6.e092284.12","unstructured":"Guidelines on perioperative management of anticoagulant and antiplatelet agents. Sydney: NSW Government, 2018."},{"key":"2025121401034394000_15.6.e092284.13","first-page":"213","article-title":"Thromboembolism after elective and post-traumatic hip surgery--a controlled prophylactic trial with dextran 70 and low-dose heparin","volume":"145","author":"Bergqvist","year":"1979","journal-title":"Acta Chir Scand"},{"key":"2025121401034394000_15.6.e092284.14","first-page":"273","article-title":"Anaesthetic techniques and thromboembolism in total hip arthroplasty","volume":"3","author":"Fredin","year":"1986","journal-title":"Eur J Anaesthesiol"},{"key":"2025121401034394000_15.6.e092284.15","article-title":"Deep vein thrombosis following knee replacement: The role of thrombosis prophylaxis combined with epidural anesthesia","volume":"66","author":"Rodrigo","year":"1994","journal-title":"Haemostasis"},{"key":"2025121401034394000_15.6.e092284.16","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-200106270-00014"},{"key":"2025121401034394000_15.6.e092284.17","unstructured":"Gruessner AC , Sutherland DE . Analysis of United States (US) and non-US pancreas transplants as reported to the International Pancreas Transplant Registry (IPTR) and to the United Network for Organ Sharing (UNOS). Clin Transpl 1998;53\u201373."},{"key":"2025121401034394000_15.6.e092284.18","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1016\/j.transproceed.2020.10.020","article-title":"Use of Dextran 40 After Pancreas Transplant May Reduce Early Inflammation and Significant Bleeding Compared to a Heparin-Based Protocol","volume":"53","author":"Innes","year":"2021","journal-title":"Transplant Proc"},{"key":"2025121401034394000_15.6.e092284.19","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1097\/TP.0000000000002425","article-title":"Open Randomized Multicenter Study to Evaluate Safety and Efficacy of Low Molecular Weight Sulfated Dextran in Islet Transplantation","volume":"103","author":"von Zur-M\u00fchlen","year":"2019","journal-title":"Transplantation"},{"key":"2025121401034394000_15.6.e092284.20","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-6143.2008.02541.x"},{"key":"2025121401034394000_15.6.e092284.21","doi-asserted-by":"publisher","DOI":"10.1053\/jlts.2003.50098"},{"key":"2025121401034394000_15.6.e092284.22","doi-asserted-by":"crossref","DOI":"10.1111\/ctr.14629","article-title":"What is the optimal management of thromboprophylaxis after liver transplantation regarding prevention of bleeding, hepatic artery, or portal vein thrombosis? A systematic review of the literature and expert panel recommendations","volume":"36","author":"Kirchner","year":"2022","journal-title":"Clin Transplant"},{"key":"2025121401034394000_15.6.e092284.23","doi-asserted-by":"crossref","first-page":"752","DOI":"10.4254\/wjh.v10.i10.752","article-title":"Thrombosis prophylaxis in pediatric liver transplantation: A systematic review","volume":"10","author":"Nacoti","year":"2018","journal-title":"World J Hepatol"},{"key":"2025121401034394000_15.6.e092284.24","unstructured":"Melbourne TRCsH . Liver transplant protocol. Post-operative Management; 2012."},{"key":"2025121401034394000_15.6.e092284.25","doi-asserted-by":"publisher","DOI":"10.1016\/j.jvs.2006.01.006"},{"key":"2025121401034394000_15.6.e092284.26","first-page":"229","article-title":"Low-molecular-weight dextran-induced anaphylactic shock immediately after intracoronary imaging","volume":"26","author":"Dai","year":"2022","journal-title":"J Cardiol Cases"},{"key":"2025121401034394000_15.6.e092284.27","first-page":"253","article-title":"Adverse reactions to dextran in Sweden 1970-1979","volume":"149","author":"Ljungstr\u00f6m","year":"1983","journal-title":"Acta Chir Scand"},{"key":"2025121401034394000_15.6.e092284.28","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1177\/0310057X8701500208","article-title":"A prospective study of dextran-induced anaphylactoid reactions in 5745 patients","volume":"15","author":"Paull","year":"1987","journal-title":"Anaesth Intensive Care"},{"key":"2025121401034394000_15.6.e092284.29","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.avsg.2023.03.011","article-title":"Intraoperative Infusion of Dextran Confers No Additional Benefit after Carotid Endarterectomy but Is Associated with Increased Perioperative Major Adverse Cardiac Events","volume":"97","author":"Moore","year":"2023","journal-title":"Ann Vasc Surg"},{"key":"2025121401034394000_15.6.e092284.30","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/j.jvs.2012.09.017","article-title":"Intraoperative use of dextran is associated with cardiac complications after carotid endarterectomy","volume":"57","author":"Farber","year":"2013","journal-title":"J Vasc Surg"},{"key":"2025121401034394000_15.6.e092284.31","doi-asserted-by":"publisher","DOI":"10.1186\/1748-5908-5-69"},{"key":"2025121401034394000_15.6.e092284.32","doi-asserted-by":"publisher","DOI":"10.1080\/1364557032000119616"},{"key":"2025121401034394000_15.6.e092284.33","doi-asserted-by":"publisher","DOI":"10.7326\/M18-0850"}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2024-092284","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,14]],"date-time":"2025-12-14T09:03:55Z","timestamp":1765703035000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2024-092284"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":33,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2025,6,30]]},"published-print":{"date-parts":[[2025,6]]}},"alternative-id":["10.1136\/bmjopen-2024-092284"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2024-092284","relation":{},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"type":"print","value":"2044-6055"},{"type":"electronic","value":"2044-6055"}],"subject":[],"published":{"date-parts":[[2025,6]]}}}